Products

What will AGI do for Beraprost?

This classification denotes a prostaglandin analogue with the molecular formula C24H30O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 35E3NJJ4O6, chemically known as 2-hydroxy-1-(3-hydroxy-4-methyl-1-octen-6-ynyl)-2,3,3a,8b-tetrahydro-1h-cyclopenta(b)benzofuran-5-butanoic acid but generally known as beraprost, which bears US NIH Compound Identifier 5282428. Beraprost most often comes in base and sodium forms. European Medicines Agency schedules Beraprost in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05779MIG. World Health Organization schedules beraprost in its Anatomical Therapeutic Chemical (ATC) Classification. BERAPROST is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule beraprost under HS 29375000 and SITC 54156. As of Q4 2014, BERAPROST remains the US FDA Preferred Term for this commodity. Beraprost bears US NLM identifiers UMLS ID C0053336 and NCI Concept Code C76896. SMILES: O1C2C(C(C(O)C2)/C=C/C(O)C(CC#CC)C)C2C1C(CCC2)CCCC(=O)O.